SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma informs about newspaper advertisement

10 Jul 2024 Evaluate

Pursuant to Regulation 30 read with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and in compliance with various circulars issued by the Ministry of Corporate Affairs, Mankind Pharma has informed that it enclosed copies of newspaper advertisement published in Financial Express in English language and Jansatta in Hindi language on July 10, 2024 regarding ensuing Annual General Meeting of the Company to be held on Friday, August 9, 2024 through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM) and information relating to e-voting.

The above information is a part of company’s filings submitted to BSE.

Mankind Pharma Share Price

2123.20 18.50 (0.88%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×